Live Breaking News & Updates on Eric Lefebvre

Stay updated with breaking news from Eric lefebvre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $14.58

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $14.58, but opened at $15.73. Pliant Therapeutics shares last traded at $17.14, with a volume of 766,465 shares. Wall Street Analyst Weigh In Several equities research analysts have commented on […] ....

Nova Scotia , United States , Bernard Coulie , Eric Lefebvre , Pricet Rowe Associates Inc , Needham Company , Pliant Therapeutics Inc , Cantor Fitzgerald , Securities Exchange Commission , Blackrock Inc , Fred Alger Management , Royal Bank , Capital International Investors , Jpmorgan Chase Co , Pliant Therapeutics , Get Free Report , Exchange Commission , Alger Management , Street Corp , Pliant Therapeutics Daily , Nasdaq Plrx ,

Pliant Therapeutics (NASDAQ:PLRX) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a report published on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $63.00 target price on the stock. A number of other equities research analysts also recently weighed in on the company. HC Wainwright reiterated a buy rating […] ....

United States , Hong Kong , Eric Lefebvre , Mike Ouimette , Jpmorgan Chase Co , Y Intercept Hong Kong Ltd , Cantor Fitzgerald , Tekla Capital Management , Needham Company , Canaccord Genuity Group , Pliant Therapeutics Company Profile , Pliant Therapeutics Inc , Fernwood Investment Management , Securities Exchange Commission , Pliant Therapeutics , Free Report , Genuity Group , Therapeutics Trading Down , Get Free Report , Exchange Commission , General Counsel Mike Ouimette , Intercept Hong Kong Ltd , Investment Management , Capital Management , Hill Capital Management , Pliant Therapeutics Daily ,

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Rating of "Buy" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has earned a consensus rating of “Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Eleven investment analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have updated their coverage on the stock in […] ....

United States , Mike Ouimette , Eric Lefebvre , Tekla Capital Management , Virtu Financial , Jpmorgan Chase Co , Canaccord Genuity Group , Pliant Therapeutics Inc , Needham Company , Royal Bank , Securities Exchange Commission , Fernwood Investment Management , Pliant Therapeutics , Get Free Report , Marketbeat Ratings , Genuity Group , Therapeutics Stock Down , Exchange Commission , General Counsel Mike Ouimette , Investment Management , Capital Management , Hill Capital Management , Get Free , Pliant Therapeutics Daily , Nasdaq Plrx ,